ValiRx plc (LON:VAL – Get Free Report) traded up 24.3% during mid-day trading on Tuesday. The stock traded as high as GBX 0.17 and last traded at GBX 0.17. 33,471,961 shares changed hands during trading, an increase of 153% from the average session volume of 13,205,922 shares. The stock had previously closed at GBX 0.14.
ValiRx Stock Performance
The firm has a market capitalization of £2.30 million, a PE ratio of -0.42 and a beta of 0.59. The stock has a fifty day moving average price of GBX 0.14 and a 200-day moving average price of GBX 0.22.
ValiRx (LON:VAL – Get Free Report) last issued its quarterly earnings data on Tuesday, September 15th. The company reported GBX (0.09) earnings per share for the quarter. ValiRx had a negative net margin of 6,548.06% and a negative return on equity of 71.49%. Research analysts expect that ValiRx plc will post -1.74 earnings per share for the current fiscal year.
ValiRx Company Profile
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Further Reading
- Five stocks we like better than ValiRx
- Microsoft’s Neocloud Pullback Isn’t a Crack in AI Demand
- Fox’s $22 Billion Roku Acquisition Reshapes Its Streaming Business
- DraftKings Just Lost 20%—And Its Biggest Gamble Is Still Ahead
- Barrick’s Earnings Beat Could Be Overshadowed by an Even Bigger Opportunity
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
